0001209191-19-021305.txt : 20190326
0001209191-19-021305.hdr.sgml : 20190326
20190326160749
ACCESSION NUMBER: 0001209191-19-021305
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190326
DATE AS OF CHANGE: 20190326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zuo William Wei
CENTRAL INDEX KEY: 0001427110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 19705382
MAIL ADDRESS:
STREET 1: 3040 POST OAK BLVD
STREET 2: SUITE 1110
CITY: HOUSTON
STATE: TX
ZIP: 77056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-25
0
0001300699
Athenex, Inc.
ATNX
0001427110
Zuo William Wei
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
0
1
0
0
President, China Division
Common Stock
2019-03-25
4
P
0
1000
12.47
A
1118777
D
Stock Option (Right to Buy)
7.50
2025-06-11
Common Stock
120000
120000
D
Stock Option (Right to Buy)
11.00
2018-06-13
2027-06-13
Common Stock
1
1
D
Stock Option (Right to Buy)
17.30
2028-03-27
Common Stock
25000
25000
D
Stock Option (Right to Buy)
13.17
2029-02-28
Common Stock
25000
25000
D
This transaction was executed in multiple trades ranging from $12.39 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
The option vests in three equal installments beginning on June 11, 2016.
This option vests in four equal annual installments beginning on March 27, 2019.
The option vests in four equal annual installments beginning on February 28, 2020.
/s/ Teresa Bair, Attorney-in-Fact
2019-03-26